The demand for generic drugs has been on the rise globally and India is no exception to it. Here are some key points regarding the trend in the sale of generic drugs in India over the past few years:

• According to data from PharmaStat, the Indian generic drug market is expected to grow at a CAGR of 15.7% and reach $33.7 billion by 2023.
• Since the launch of India's generic drug program in 2015, the demand for generic drugs has increased significantly with more people preferring generic over branded drugs due to the lower cost.
• The Government of India's push towards increasing access to healthcare and affordable medicines has further boosted the demand for generic drugs in the country.
• According to a report by IQVIA, more than 80% of the drugs sold in the Indian market are generics, and the market share of generic drugs is expected to rise further in the future years.
• The COVID-19 pandemic has also led to an increased demand for generic drugs as patients look for cost-effective treatment options amidst the economic slowdown.

Overall, the outlook for the Indian generic drug market looks positive, with increasing demand and government support driving growth in this sector.